Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
39 studies found for:    Mitochondrial Myopathies
Show Display Options
Rank Status Study
21 Terminated Quality of Life in Patients With Statin-Associated Myopathy
Condition: Statin-Associated Myopathy
Interventions: Drug: Statins;   Drug: Lactose placebo pills
22 Recruiting Mechanisms That Produce the Leg Dysfunction of Claudication (Leg Pain and Limping During Walking) and Treatment Strategies for the Care of Patients With Claudication
Condition: Peripheral Arterial Disease
Interventions: Procedure: Revascularization Surgery;   Other: Supervised exercise therapy
23 Recruiting Open-Label, Dose-Escalating Study to Assess Safety, Tolerability, Efficacy, PK and PD of RP103 in Children With Inherited Mitochondrial Disease
Condition: Inherited Mitochondrial Disease, Including Leigh Syndrome
Intervention: Drug: Cysteamine Bitartrate Delayed-release Capsules (RP103)
24 Withdrawn Muscle Characteristics Associated With Statin Therapy
Conditions: Hydroxymethylglutaryl-CoA Reductase Inhibitors;   Myopathy
Intervention: Drug: simvastatin
25 Completed Low Protein Diet in Patients With Collagen VI Related Myopathies
Conditions: Bethlem Myopathy;   Ullrich Congenital Muscular Dystrophy
Intervention: Other: Low protein diet
26 Recruiting Early Goal-Directed Nutrition in ICU Patients - EAT-ICU Trial
Conditions: Critical Illness;   Intensive Care (ICU) Myopathy;   Muscle Wasting;   Loss of Physical Function;   Mechanical Ventilation
Interventions: Other: Early Goal-Directed Nutrition;   Other: ASPEN-guidelines
27 Recruiting Effect of Vitamin D Supplementation on Exercise Adaptations in Patients on Statin Therapy
Condition: [X]Statin Causing Adverse Effect in Therapeutic Use
Interventions: Drug: vitaminD;   Drug: Simvastatin;   Drug: Placebo
28 Completed Therapy for Chronic Fatigue Syndrome: A Presumptive Mitochondrial Disorder
Condition: Chronic Fatigue Syndrome
Intervention: Drug: Nutraceuticals
29 Enrolling by invitation Natural History of Pearson Syndrome
Condition: Pearson Syndrome
Intervention:
30 Unknown  Chronic Fatigue Syndrome: A Presumptive Mitochondrial Disorder
Condition: Chronic Fatigue Syndrome
Interventions: Drug: Nutraceutical supplements;   Drug: Placebo
31 Recruiting Phase 2 Study of EPI-743 in Children With Pearson Syndrome
Condition: Pearson Syndrome
Intervention: Drug: EPI-743
32 Completed Effects of Parenteral L-carnitine Supplementation in Premature Neonates
Condition: Complication of Prematurity
Interventions: Drug: Parenteral L-carnitine supplementation;   Drug: Parenteral supplementation with sterile water
33 Recruiting Neural Mechanisms Engaged in Control of Eye Movements
Conditions: Degenerative Diseases of the Central Nervous System;   Ocular-motor and Vestibular Diseases
Intervention:
34 Recruiting Use of (-)-Epicatechin in the Treatment of Becker Muscular Dystrophy (Pilot Study)
Condition: Becker Muscular Dystrophy
Intervention: Drug: (-)-epicatechin
35 Active, not recruiting The Synergy Trial: Methylphenidate Plus a CFS-Specific Nutrient Formula as a Treatment for Chronic Fatigue Syndrome
Conditions: Chronic Fatigue Syndrome (CFS);   Myalgic Encephalomyelitis (ME)
Interventions: Drug: Methyl-P plus Nutrient Formula;   Drug: Methyl-P plus Nutrient matched placebos
36 Unknown  Bezafibrate Trial in CPT2 Deficiency
Condition: Carnitine Palmitoyl Transferase 2 Deficiency
Intervention: Drug: bezafibrate (drug)
37 Completed
Has Results
Efficacy and Tolerability of Idebenone in Boys With Cardiac Dysfunction Associated With Duchenne Muscular Dystrophy
Condition: Duchenne Muscular Dystrophy (DMD)
Interventions: Drug: idebenone;   Drug: placebo
38 Completed Assessing Immune Function in Young Patients With Cytopenia That Did Not Respond to Treatment
Conditions: Dyskeratosis Congenita;   Fanconi Anemia;   Myelodysplastic Syndromes;   Pearson Marrow-pancreas Syndrome;   Shwachman-diamond Syndrome
Interventions: Genetic: polymerase chain reaction;   Other: flow cytometry;   Other: immunologic technique;   Procedure: biopsy
39 Completed Effect of Bezafibrate on Muscle Metabolism in Patients With Fatty Acid Oxidation Defects
Conditions: Carnitine Palmitoyltransferase II Deficiency;   Very Long Chain Acyl Coa Dehydrogenase Deficiency
Interventions: Drug: Bezafibrate;   Other: Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-39) Next Page   
Indicates status has not been verified in more than two years